Overexpressed eNOS upregulates SIRT1 expression and protects mouse pancreatic β cells from apoptosis

Tingting Hu1, Ye Chen2, Qian Jiang3

  • 1Department of Biotechnology, Guilin Medical University, Guilin, Guangxi 541004, P.R. China.

Insights

Overexpressed endothelial nitric oxide synthase (eNOS) promotes pancreatic beta cell proliferation and inhibits apoptosis by activating sirtuin 1 (SIRT1). This suggests eNOS may be a therapeutic target for type 2 diabetes.

Area of Science:

  • Cell Biology
  • Metabolic Diseases
  • Molecular Biology

Background:

  • Sirtuin 1 (SIRT1) activity loss is linked to metabolic diseases like diabetes.
  • Endothelial nitric oxide synthase (eNOS) role in pancreatic beta cells is not fully understood.

Purpose of the Study:

  • Investigate eNOS effects on Min6 cell proliferation and apoptosis.
  • Examine the link between eNOS overexpression and SIRT1 activation.

Main Methods:

  • Constructed and transfected pcDNA3.0-eNOS plasmid into Min6 cells.
  • Validated eNOS and SIRT1 expression using RT-qPCR and Western blot.
  • Assessed cell proliferation (CCK-8) and apoptosis (flow cytometry).
  • Explored eNOS-SIRT1 interaction via co-immunoprecipitation.

Main Results:

  • Overexpressed eNOS significantly upregulated both eNOS and SIRT1 expression.
  • eNOS overexpression promoted Min6 cell proliferation.
  • eNOS overexpression inhibited Min6 cell apoptosis.
  • Confirmed a strong interaction between eNOS and SIRT1.

Conclusions:

  • Overexpressed eNOS induces SIRT1 activation in Min6 cells.
  • eNOS activation plays a protective role in pancreatic beta cells.
  • eNOS represents a potential therapeutic target for type 2 diabetes.